glucagon in retatrutide ly3437943 triple agonist glp-1 gip mechanism Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Glucagon and retatrutide‐induced ANGPTL3/8 secretion

Most people dont gain weight on semaglutide, though other factors like overeating and underlying health conditions can cause weight gain

24 Age-changes in GH secretory dynamics at later stages of life are clinically measurable as frank alterations of the earlier patterns that can be quantified by measurement of pulse timing and amplitude

Diabetes Care 38 , 119125 (2015)

I would rather know early, because correcting B12 deficiency takes time

Cells involved in repair (fibroblasts, endothelial cells, muscle cells) appear to respond through signaling changes that support migration, collagen organization, and local tissue rebuilding